Dow Up0.76% Nasdaq Up0.69%

United Therapeutics Corporation (UTHR)

132.35 Up 3.57(2.78%) Oct 24, 4:00PM EDT
|After Hours : 132.35 0.00 (0.00%) Oct 24, 4:57PM EDT
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):2.4
Mean Recommendation (last week):2.4

* (Strong Buy) 1.0 - 5.0 (Sell)

Price Target Summary
Mean Target:117.64
Median Target:105.00
High Target:165.00
Low Target:79.00
No. of Brokers:14

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
Oct 15, 2014Standpoint ResearchUpgradeHoldBuy
Apr 7, 2014Standpoint ResearchUpgradeHoldBuy
Dec 23, 2013Ladenburg ThalmannUpgradeNeutralBuy
Jul 30, 2013Standpoint ResearchDowngradeBuyHold
Jun 20, 2013Standpoint ResearchUpgradeHoldBuy
May 15, 2013Standpoint ResearchDowngradeBuyHold
Aug 3, 2012Standpoint ResearchDowngradeBuyHold
Apr 27, 2012Canaccord GenuityDowngradeBuyHold
Mar 26, 2012Canaccord GenuityInitiated Buy
Mar 12, 2012Standpoint ResearchInitiated Buy

More Upgrades & Downgrades for UTHR

Data provided by - Take a free trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy3333

Data provided by Thomson/First Call

Currency in USD.